The AAN and AHS have issued updated 2026 practice guidelines for the pharmacologic prevention and treatment of migraine among ...

Adults aged 40 years and older with symptoms of cognitive impairment may now qualify for a recently approved blood test for Alzheimer disease.

Flexible-dose tavapadon significantly improves motor symptoms among patients with early-stage Parkinson disease.

Periconception parental vitamin B12 and postconception maternal RBC folate are associated with lower prevalence of birth defects.

As health care costs increase, many companies plan to reduce benefits and health care coverage to avoid that additional expense.

There is an independent association between xylitol and incident risk for major cardiovascular events among the general population.

Delayed presurgical evaluation for pediatric drug-resistant epilepsy is linked to lower odds of seizure freedom following epilepsy surgery ...

Plasma p-tau217 levels may not be a reliable biomarker for early cognitive impairment in patients with Parkinson disease without dementia.

Exposure to wildfire-related fine particulate matter is associated with an increase in emergency department visits for migraine and primary headaches.

Black patients with multiple sclerosis experience higher mortality rates and die at younger ages than other racial and ethnic groups.

The risk for antenatal complications is increased in association with maternal multiple long-term conditions (MLTCs).

Leucovorin dispensing rates increased significantly between December 2024 and December 2025, corresponding with an FDA press release discussing a potential association between autism spectrum disorder ...